http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2007505140-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-65 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-04 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N- |
| filingDate | 2004-09-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2007-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2007505140-A |
| titleOfInvention | Treatment of insulin-like growth factor-1 (IGF-1) deficiency |
| abstract | The present invention provides methods and compositions that increase growth rate, alleviate symptoms, or improve metabolism in human patients with insulin-like growth factor-1 deficiency (IGFD). The present invention provides a height that is at least about 2 standard deviations below the normal mean of subjects of the same age and sex at the time of or prior to treatment with IGF-1, normal mean levels at or prior to the start of treatment with IGF-1. In connection with a method comprising administering insulin-like growth factor-I to a patient having a blood level of insulin-like growth factor-1 that is below, usually at least about one standard deviation below the normal mean level of age and sex Yes. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2019217186-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019156540-A1 |
| priorityDate | 2003-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 326.